CVKD · Cadrenal Therapeutics, Inc. · Proposed Sales
$1.22
+0.02 (+1.58%)
At close · Sep 9
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors, among others, raise substantial doubt about the Company's ability to continue as a going concern for at least one year from the date the accompanying financial statements are issued.”View the 10-Q filed Aug 13, 2026
Market Cap
$4.28M
Shares
3.57M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2025-12-29 | MATTHEW K SZOT | Officer | 9,933 | 2025-12-29 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-10-27 | Quang X. Pham | Officer | 1,315 | 2025-10-27 | Merrill Lynch |
| 2025-10-27 | MATTHEW SZOT | Officer | 1,800 | 2025-10-27 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-10-24 | MATTHEW SZOT | Officer | 1,800 | 2025-10-24 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-10-24 | Quang X. Pham | Officer | 1,129 | 2025-10-24 | Merrill Lynch |
| 2025-10-14 | Quang X. Pham | Officer | 1,800 | 2025-10-13 | Merrill Lynch |
| 2025-10-14 | MATTHEW SZOT | Officer | 1,800 | 2025-10-13 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-10-09 | Quang X. Pham | Officer | 1,800 | 2025-10-09 | Merrill Lynch |
| 2025-10-09 | MATTHEW SZOT | Officer | 1,693 | 2025-10-09 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-10-06 | MATTHEW SZOT | Officer | 107 | 2025-10-06 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-10-02 | Quang X. Pham | Officer | 500 | 2025-10-02 | Merrill Lynch |
| 2025-10-01 | MATTHEW SZOT | Officer | 1,700 | 2025-10-01 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-10-01 | Quang X. Pham | Officer | 881 | 2025-10-01 | Merrill Lynch |
| 2025-09-29 | MATTHEW SZOT | Officer | 100 | 2025-09-29 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-09-29 | Quang X. Pham | Officer | 419 | 2025-09-29 | Merrill Lynch |
| 2025-09-25 | Quang X. Pham | Officer | 6,790 | 2025-09-24 | Merrill Lynch |
| 2025-09-25 | MATTHEW SZOT | Officer | 10,900 | 2025-09-25 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-09-24 | Quang Pham | Officer | 2,581 | 2025-09-24 | Merrill Lynch |
| 2025-09-24 | MATTHEW SZOT | Officer | 1,500 | 2025-09-24 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-08-28 | MATTHEW SZOT | Officer | 400 | 2025-08-28 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-08-28 | Pham Quang X | Officer | 1,193 | 2025-08-28 | Merrill Lynch |
| 2025-08-27 | Pham Quang X | Officer | 30,600 | 2025-08-27 | Merrill Lynch |
| 2025-08-27 | MATTHEW SZOT | Officer | 1,600 | 2025-08-27 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Showing 1–23 of 23 filings
Key facts
CIK
1937993
CUSIP
127636207
13F (30d)
13 filings
13 filers
Visit website
Investor relations